Han Kun Law Offices

The Cyberspace Administration of China (CAC) issued theProvisions on Regulating and Promoting Cross-Border Data Flows (Draft for Comments)(《规范和促进数据跨境流动规定（征求意见稿）》)on September 28, 2023 seeking public comments, which garnered significant attention. Yesterday (March 22, 2024), the CAC issued the official version of theProvisions on Promoting and Regulating Cross-Border Data Flows(《规范和促进数据跨境流动规定》)(the "Official Provisions"), which came into effect immediately upon publication...

On 14 March 2024, the National Development and Reform Commission("NDRC") of the People's Republic of China ("PRC") issued theCircular on Supporting Quality Enterprises to Borrow Medium-and Long-term Foreign Debts to Promote Quality Development of the Real Economy (Draft for Comments)(the "Draft Circular")(《国家发展改革委关于支持优质企业借用中长期外债 促进实体经济高质量发展的通知（征求意见稿）》) to solicit public opinion from 14 March 2024 to 13 April 2024...

Han Kun Law Offices represented Raytech Holding Limited ("Raytech Holding", NASDAQ: RAY), as PRC and Hong Kong counsel to the issuer, in connection with the initial public offering and listing of its ordinary shares on the Nasdaq Capital Market.Raytech Holding is principally engaged in the sourcing and wholesaling of personal care electrical appliances including hair styling, trimmer, neck care, and nail care products for international brand owners and providing product design and development collaboration as a value-added service...

Recently, Beijing QL Biopharmaceutical Co., Ltd. ("QL Biopharm") and Tonghua Dongbao Pharmaceutical Co., Ltd. ("Tonghua Dongbao") entered into a collaboration agreement, according to which Tonghua Dongbao will obtain exclusive commercialization rights in the Chinese mainland for QL Biopharm's GLP-1 product, Semaglutide Injection (indication: glycemic control in adult patients with type 2 diabetes). In addition, the two parties will collaborate on developing the product in overseas markets.In recent years, GLP-1 products have demonstrated significant value in the treatment of diabetes and weight management. The GLP-1 product in this collaboration is Semaglutide, a long-acting GLP-1 analogue...